Robert Pilarski, MS, LGC, MSW, a certified genetic counselor, reviews the range of options currently available for genetic screening for prostate cancer. He weighs the advantages and disadvantages of different options for genetic testing, suggests criteria for selecting a lab, and discusses controversies with direct-to-consumer genetic testing.Read More
Robert Pilarski, MS, LGC, MSW, LSW
The Ohio State University
Robert Pilarski, is a licensed and board-certified genetic counselor and Professor of Clinical Internal Medicine at the Wexner Medical Center and James Comprehensive Cancer Center at The Ohio State University. Mr. Pilarski’s clinical responsibilities include counseling patients and families with a variety of cancer syndromes about cancer risks, genetic testing, and medical management. In addition, he researches on clinical aspects of Cowden syndrome and the PTEN Hamartoma Tumor syndrome (PHTS), and he is the study coordinator and co-investigator for the OSU Breast Cancer Tissue Bank and a study on the Genetics of Uveal Melanoma, which helped identify BAP1 as a tumor predisposition gene. He has over 80 publications in medical and scientific journals. He has presented regularly at national and regional conferences, and has served as an ad hoc review for numerous medical and genetics journals. Mr. Pilarski was a past board member of the National Society of Genetic Counselors, and co-founder and past president of its Cancer Genetics Special Interest Group. He is the vice-chair of the National Comprehensive Cancer Network’s guidelines panel on Genetic/Familial High-Risk Assessment: Breast and Ovarian Cancers.